News
Researchers have found new compounds that could be used to treat a common breast cancer that can be resistant to hormone ...
6mon
SurvivorNet on MSNMajor New Drug Approval For Preventing Recurrence In Early Stage Breast Cancer Patients: Weighing The Risks & Benefits of KisqaliIn a long awaited approveall, The Food and Drug Administration (FDA) has just approved the drug Kisqali (ribociclib) in ...
Aromatase inhibition could be an alternative to testosterone administration to mitigate declining androgen production in hypogonadal older men. Unlike testosterone replacement, aromatase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results